Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities

dc.contributor.authorKaya, Betül
dc.contributor.authorMaryam, Zahra
dc.contributor.authorDaoud, Nour El Huda
dc.contributor.authorBağcı, Emine Rana
dc.contributor.authorKarakaya, Abdüllatif
dc.contributor.authorErçeti?n, Tu?ba
dc.contributor.authorÇevik, Ulviye Acar
dc.date.accessioned2026-02-06T17:59:21Z
dc.date.issued2025
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractIn this study, a novel series of benzofuran derivatives (2a-2k) was synthesized, and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR, and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 ?M concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to the DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 ?M, when compared to standard gallic acid (IC50 29.48 ± 0.014 ?M). Furthermore, compounds 2d (10.33%) and 2i (20.17%) showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease. © 2025, Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved.
dc.identifier.doi10.55262/fabadeczacilik.1678454
dc.identifier.endpage546
dc.identifier.issn1300-4182
dc.identifier.issue3
dc.identifier.scopus2-s2.0-105027100051
dc.identifier.scopusqualityQ3
dc.identifier.startpage531
dc.identifier.urihttps://doi.org/10.55262/fabadeczacilik.1678454
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/
dc.identifier.urihttps://hdl.handle.net/11129/8041
dc.identifier.volume50
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSociety of Pharmaceutical Sciences of Ankara (FABAD)
dc.relation.ispartofFabad Journal of Pharmaceutical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20260204
dc.subjectAlzheimer’s disease
dc.subjectanticholinesterase
dc.subjectBenzofuran
dc.subjectDPPH assay
dc.subjectferrous ion-chelating activity
dc.titleSynthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities
dc.title.alternativeBenzofuran Temelli Yeni Tiyazol Hibritlerinin Sentezi ve Antioksidan ve Antikolinesteraz Aktivitelerinin İncelenmesi
dc.typeArticle

Files